Exercise for Patients With HIV Infections

Phase 2

• Conditions: HIV Infections; Lipodystrophy; Inflammation
• Interventions: Behavioral: Exercise

• Registration Number: NCT00910936
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

The investigators will evaluate the effects of an endurance exercise program on the physical performance, the well being, and indicators of metabolic function in patients with an HIV infection.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-05
• Study First Submitted: 2009-05-29
• Study First Submitted QC: 2009-05-29
• Study First Posted: 2009-06-01
• Status Verified: 2009-12
• Last Update Submitted: 2009-12-18
• Last Update Posted: 2009-12-21
• Primary Completion: 2010-01
• Study Completion: 2010-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Age 18 to 65
• HIV infection
• Antiviral therapy
• Understanding of written German

Exclusion Criteria

• Diabetes mellitus
• All conditions which can be aggravated by exercise

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	Exercise	-

Primary Outcome Measures

Name	Time	Method
Maximal oxygen uptake (VO2max)	At recruitment and after 12 weeks

Secondary Outcome Measures

Name	Time	Method
Quality of life	At recruitment and after 12 weeks
Indicators of fat metabolism	At recruitment and after 12 weeks
Markers of inflammation	At recruitment and after 12 weeks

Trial Locations

Locations (1)

Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30; 🇩🇪 Berlin, Germany